XML 356 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisitions and Divestitures - Narrative (Details)
$ in Thousands
12 Months Ended 24 Months Ended
Dec. 04, 2023
USD ($)
Oct. 10, 2023
USD ($)
payment
Sep. 27, 2022
USD ($)
payment
Jun. 28, 2021
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2023
USD ($)
May 15, 2021
USD ($)
Business Acquisition [Line Items]                  
Contingent consideration liability         $ 39,486 $ 44,022   $ 39,486  
Goodwill         2,914,055 2,536,730 $ 2,504,202 2,914,055  
Proceeds from sale of assets         15,000 12,434 224,909    
Net revenues         2,974,489 2,791,041 2,809,563    
Acquisitions, contingent consideration, liability         27,000 43,168 0    
Standard Bariatrics                  
Business Acquisition [Line Items]                  
Business combination, consideration transferred     $ 173,000            
Number of milestone payments | payment     3            
Aggregate contingent consideration amount     $ 130,000            
Goodwill     71,400            
Intangible assets     $ 154,500            
Standard Bariatrics | Maximum                  
Business Acquisition [Line Items]                  
Contingent consideration liability         177,000     177,000  
Palette Life Sciences AB                  
Business Acquisition [Line Items]                  
Business combination, consideration transferred   $ 621,900              
Acquisition operating Loss         5,600        
Fair value of consideration transferred   594,900              
Contingent consideration liability   $ 27,000              
Number of milestone payments | payment   2              
Aggregate contingent consideration amount   $ 50,000              
Business combination, acquisition related costs         10,600        
Goodwill   357,025              
Intangible assets   $ 333,500              
Respiratory Business | Disposal Group, Held-for-sale, Not Discontinued Operations                  
Business Acquisition [Line Items]                  
Disposal group, including discontinued operation, consideration                 $ 286,000
Disposal group, including discontinued operation, working capital                 $ 12,000
Proceeds from sale of assets       $ 259,000       $ 15,000  
Gain on disposition of business $ 4,400                
Revenue attributable to respiratory business             60,700    
Respiratory Business | Disposal Group, Held-for-sale, Not Discontinued Operations | Medline Manufacturing And Supply Transition Agreement                  
Business Acquisition [Line Items]                  
Net revenues         $ 75,700 $ 79,100 $ 51,100